A61K 31/22, A61K 2300/00, A61K 31/198, A61K 31/23, A61K 45/06, A61K 47/14, A61K 47/26, A23L 33/10, A23L 33/12, A23L 3/00, A61P 21/06
Methods and compositions for treating or preventing muscle wasting resulting from an underlying disease or disorder, such as cancer cachexia. A therapeutically effective amount of a ketogenic supplementâsuch as R,S 1,3 butanediol diacetoacetate, R,S 1,3-butanediol acetoacetate diester, derivatives thereof, or combinations thereofâis administered to a patient or subject in need. The ketogenic supplement may further include a medium chain triglyceride in combination with the ketone ester.
Koutnik, Andrew Paul and D'Agostino, Dominic Paul, "Prevention and treatment of muscle wasting with ketone supplementation" (2022). USF Patents. 1306.
University of South Florida